Minnesota medicinal cannabis provider LeafLine Labs has named Haberman its agency of record to introduce LeafLine’s public-facing brand experience through website development, public relations, provider and patient education and overall marketing services.
“Haberman is an ideal choice to represent LeafLine Labs in our patient and provider outreach, communication and marketing efforts as we launch on the frontier of the medicinal cannabis industry in Minnesota. The agency’s deep experience with top-tier health care, education and wellness-focused clients will be an advantage as we tell our story to our many audiences,” said Andrew Bachman, co-founder and CMO, LeafLine Labs. “Haberman will facilitate education — and deliver strong communications to broader constituencies across our state— we know we’re in good company.”
“We are proud to work with LeafLine Labs to help set the standard in this emerging market,” said Fred Haberman, co-founder and CEO, Haberman. “We believe that LeafLine will be a model — not only in Minnesota but across the United States — for how the medicinal cannabis industry can best meet the needs of patients who may benefit from this medicine.”
LeafLine Labs is one of only two Minnesota organizations licensed to cultivate, process and distribute medicinal cannabis as part of the state’s new medicinal cannabis program, launching July 1, 2015. Focused on its mission to become the pre-eminent provider of the highest-quality medicinal cannabis, the company will work to improve the lives of Minnesotans suffering from medical conditions that stand to benefit from medicinal cannabis.
